You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Rapid Point-of-Care Tests for Cytomegalovirus (CMV)
SBC: BASE PAIR BIOTECHNOLOGIES INC Topic: N/AThe human cytomegalovirus (CMV) is one of the most common intrauterine transmitted viral agents, leading to congenital CMV infection in three to ten newborns per thousand. Depending on the preexisting status of the mother, this infection leads to more or less severe symptoms and in about 2-6% the infected children die as a consequence of the infection. Beside this, sequelae occur in a number of ...
SBIR Phase I 2014 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Aptamers to Detect Fungi in Formalin-Fixed Sections
SBC: Operational Techologies Corporation Topic: N/ADevelopment of novel antifungal drugs is spurring interest in the detection of pathogenic fungi in archival formalin-fixed tissues. While in situ hybridization and PCR-based methods for fungal detection in tissues exist. formaldehyde adducts on fungal DNA complicate or invalidate such detection methods. Operational Technologies Corporation (OpTech) has been developing DNA aptamers against a broad ...
SBIR Phase I 2014 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Fluorescent Lateral Flow Assay for Diagnosis of Cocciodioidomycosis
SBC: Immuno-mycologics, Inc. Topic: N/ACoccidioidomycosis, also known as Valley Fever, is a disease caused by inhalation of Coccidioides arthroconidia. This disease is endemic to the southwestern United States, parts of Mexico, and Central and South America. Every year approximately 150,000 people in the United States become infected with Coccidioides spp. Importantly, the rate of Valley Fever cases is increasing dramatically, earni ...
SBIR Phase I 2014 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Screening for Alcohol-Related Liver Disease Using Breath Signatures by DMS
SBC: APPLIED NANOTECH, INC. Topic: NIAAADESCRIPTION (provided by applicant): Alcohol abuse is rampant in the U.S., estimates run as high as 1 in 20 adults, and cost tens of billions of dollars in treatment and economic loss. One especially intransigent problem has been alcohol-induced organ disease such as alcoholic hepatitis and cirrhosis. These diseases can currently be diagnosed, but this requires invasive procedures such as liver bi ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A rapid, accurate, and easy-to-use diagnostic assay for STIs
SBC: AI BIOSCIENCES, INC. Topic: NIAIDDESCRIPTION (provided by applicant): The aim of this application is to develop a rapid, easy-to-use, and inexpensive multi-sample diagnostic system to identify sexually transmitted infection (STI) pathogens, such as Chlamydia trachomatis (CT) and Neisseriagonorrhoeae (NG) in non-traditional healthcare settings. According to the CDC, chlamydia and gonorrhea, caused by C. trachomatis and N. gonorrho ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Sensitive and Serotype-Specific Dengue Diagnostic Test for Low-Resource Setting
SBC: AI BIOSCIENCES, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Dengue is transmitted mainly by the Aedes aegypti mosquitoes which inhabit the tropics, making Dengue endemic to these areas. It is caused by four genetically and serologically related viruses, termed DENV1, DENV2, DENV3, and DENV4. Dengue infection is a leading cause of illness and death in the tropics and subtropics, including Puerto Rico and the U.S. Virgin ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Efficacy Photodynamic Disinfection
SBC: LYNNTECH INC. Topic: NIAIDPROJECT SUMMARY This proposal is in response to the NIAID Advanced Technology SBIR (PA-10-123) Funding Opportunity. This Phase I feasibility study is an advanced technology project with a clearly identified product that will result in a clinically relevanttopical AM treatment modality. The award period and amount requested are guided by project needs and are in compliance with the issued guideline ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Studies of PG70 LEAPS Peptide Vaccines for Rheumatoid Arthritis
SBC: CEL-SCI CORPORATION Topic: NIAMSDESCRIPTION (provided by applicant): Currently, FDA-licensed pharmaceuticals used to treat rheumatoid arthritis (RA) focus largely on alleviation of symptoms, either through pain management, general immunosuppression, or by antagonizing cytokines such as TNF-?. Despite recent advances in biologic therapies, these treatments do not address the underlying autoimmune condition. Ligand epitope antigen ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Optoacoustic tomography system for image-guided cryotherapy of prostate cancer
SBC: TOMOWAVE LABORATORIES, INC. Topic: NCISummary / Abstract The objective of this Phase-I SBIR project is to develop a novel transrectal optoacoustic-ultrasonic (OU) imaging system for guiding cryotherapy of prostate cancer via real-time monitoring of ice ball formation and temperature distribution within the area of healthy tissues adjacent to the rectal wall. The proposed system will be capable of (i) non-invasive monitoring of spatial ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Assessment of Hypercoagulability in Cancer Patients Using Sonorheometry
SBC: HEMOSONICS Topic: NCIDESCRIPTION (provided by applicant): The Problem: Venous thromboembolism (VTE), which encompasses the diseases of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and life-threatening problem amongst cancer patients. In population-basedstudies, cancer has been associated with a 4-fold increase risk for VTE; in cancer patients undergoing systemic chemotherapy treatment the risk i ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health